Iscador P (Mistletoe) Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iscador P (Mistletoe) Immunotherapy, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma [Phase 2]